Biomedical Research Tower
460 West 12th Ave
At the conclusion of this activity, learners will be able to:
- Identify new diagnostic modalities available for the workup of patients with thyroid nodules
- Discuss recent advances in the treatment of refractory thyroid cancer
- Outline the indications for radioiodine therapy in differentiated thyroid cancer
- Define the appropriate indications for referral to a clinical trial in the evaluation of a patient with refractory thyroid cancer
- Discuss the mechanisms of cell signaling in the development and progression of thyroid cancer and how this knowledge impacts the diagnosis and treatment of thyroid cancer.
- Outline the controversies and current recommendations in the medical and surgical management of follicular-cell derived, and medullary thyroid cancer.
- Determine the best initial management of patients with thyroid cancer
- Recognize the potential new therapeutic targets for thyroid cancer
The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University Center for Continuing Medical Education (CCME) designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.